HIGHLIGHTS
- who: Alexandre Denoyer and collaborators from the UPMC University Paris, Institut de la Vision, UMRS968, Paris, France, INSERM, Paris, France, CNRS, Paris, France, Quinze-Vingts National have published the research work: CXCR3 Antagonism of SDF-1(5-67) Restores Trabecular Function and Prevents Retinal Neurodegeneration in a Rat Model of Ocular Hypertension, in the Journal: (JOURNAL) of February/10,/2012
- what: The authors show that the chemokine CXCL12 its truncated form SDF-1(5-67) and the receptors CXCR4 and CXCR3 are expressed in human glaucomatous trabecular tissue and a human trabecular cell line. In . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.